Rank | Gene Set | Z-score |
---|---|---|
1 | desmosome organization (GO:0002934) | 7.01120517 |
2 | hemidesmosome assembly (GO:0031581) | 5.94976747 |
3 | COPI coating of Golgi vesicle (GO:0048205) | 5.28335687 |
4 | Golgi transport vesicle coating (GO:0048200) | 5.28335687 |
5 | regulation of water loss via skin (GO:0033561) | 4.87575409 |
6 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.77998084 |
7 | sodium ion export (GO:0071436) | 4.35269487 |
8 | synaptic vesicle maturation (GO:0016188) | 4.03185405 |
9 | establishment of skin barrier (GO:0061436) | 3.99589593 |
10 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.96328690 |
11 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.91946239 |
12 | regulation of early endosome to late endosome transport (GO:2000641) | 3.80897510 |
13 | activation of Rac GTPase activity (GO:0032863) | 3.78812858 |
14 | positive regulation of nuclease activity (GO:0032075) | 3.76650375 |
15 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.71202181 |
16 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.65083537 |
17 | phosphate ion transport (GO:0006817) | 3.64356672 |
18 | protein localization to endosome (GO:0036010) | 3.62761300 |
19 | protein retention in ER lumen (GO:0006621) | 3.61700578 |
20 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.55764182 |
21 | multicellular organismal water homeostasis (GO:0050891) | 3.52112618 |
22 | thyroid hormone generation (GO:0006590) | 3.47060244 |
23 | COPII vesicle coating (GO:0048208) | 3.46876286 |
24 | positive regulation of histone deacetylation (GO:0031065) | 3.46373050 |
25 | response to parathyroid hormone (GO:0071107) | 3.41008075 |
26 | macroautophagy (GO:0016236) | 3.40225185 |
27 | intestinal epithelial cell development (GO:0060576) | 3.39284377 |
28 | regulation of nuclease activity (GO:0032069) | 3.37661663 |
29 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.37218698 |
30 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.34916813 |
31 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.31896487 |
32 | regulation of cholesterol homeostasis (GO:2000188) | 3.29007066 |
33 | phosphate ion transmembrane transport (GO:0035435) | 3.28286046 |
34 | stress fiber assembly (GO:0043149) | 3.26632450 |
35 | regulation of hippo signaling (GO:0035330) | 3.26367677 |
36 | cellular potassium ion homeostasis (GO:0030007) | 3.22297514 |
37 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.21373610 |
38 | cell-substrate junction assembly (GO:0007044) | 3.20115205 |
39 | protein localization to microtubule (GO:0035372) | 3.18356432 |
40 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.16128747 |
41 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.15921000 |
42 | positive regulation of macroautophagy (GO:0016239) | 3.14989920 |
43 | L-serine transport (GO:0015825) | 3.14741814 |
44 | proline biosynthetic process (GO:0006561) | 3.14253529 |
45 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.12173171 |
46 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.10053724 |
47 | skin morphogenesis (GO:0043589) | 3.09940532 |
48 | keratinocyte proliferation (GO:0043616) | 3.07950965 |
49 | negative regulation of cell size (GO:0045792) | 3.06892166 |
50 | cellular response to unfolded protein (GO:0034620) | 3.06233344 |
51 | water homeostasis (GO:0030104) | 3.05590117 |
52 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.01576130 |
53 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.01014148 |
54 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.99025075 |
55 | glucose 6-phosphate metabolic process (GO:0051156) | 2.98962854 |
56 | actin filament depolymerization (GO:0030042) | 2.98922766 |
57 | lysine metabolic process (GO:0006553) | 2.98840064 |
58 | lysine catabolic process (GO:0006554) | 2.98840064 |
59 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.96346795 |
60 | tricarboxylic acid metabolic process (GO:0072350) | 2.95548132 |
61 | ER-nucleus signaling pathway (GO:0006984) | 2.91828435 |
62 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.90931024 |
63 | cellular response to topologically incorrect protein (GO:0035967) | 2.88382695 |
64 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.88237660 |
65 | myelin maintenance (GO:0043217) | 2.86508052 |
66 | hormone catabolic process (GO:0042447) | 2.85591266 |
67 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.85012865 |
68 | locomotory exploration behavior (GO:0035641) | 2.84907258 |
69 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.84761012 |
70 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.82117901 |
71 | amyloid precursor protein metabolic process (GO:0042982) | 2.81979435 |
72 | mating behavior (GO:0007617) | 2.81861511 |
73 | glutamate secretion (GO:0014047) | 2.78745791 |
74 | ER overload response (GO:0006983) | 2.78102113 |
75 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.77686348 |
76 | vitamin transmembrane transport (GO:0035461) | 2.77545814 |
77 | thyroid hormone metabolic process (GO:0042403) | 2.77472522 |
78 | positive regulation of epidermis development (GO:0045684) | 2.76459446 |
79 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.76454826 |
80 | apoptotic cell clearance (GO:0043277) | 2.74204135 |
81 | cellular copper ion homeostasis (GO:0006878) | 2.73942413 |
82 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.72962687 |
83 | regulation of translational termination (GO:0006449) | 2.72952623 |
84 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.72715070 |
85 | mammary gland epithelial cell proliferation (GO:0033598) | 2.70627613 |
86 | hepatocyte apoptotic process (GO:0097284) | 2.70075294 |
87 | regulation of ARF protein signal transduction (GO:0032012) | 2.69935896 |
88 | transferrin transport (GO:0033572) | 2.69141555 |
89 | cell communication by electrical coupling (GO:0010644) | 2.68673796 |
90 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.67601338 |
91 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.67581505 |
92 | cellular zinc ion homeostasis (GO:0006882) | 2.67115700 |
93 | tight junction assembly (GO:0070830) | 2.66818836 |
94 | hypotonic response (GO:0006971) | 2.65603556 |
95 | proline transport (GO:0015824) | 2.65449431 |
96 | membrane repolarization during action potential (GO:0086011) | 2.65448297 |
97 | 4-hydroxyproline metabolic process (GO:0019471) | 2.64788750 |
98 | valine metabolic process (GO:0006573) | 2.64731015 |
99 | serine transport (GO:0032329) | 2.64679443 |
100 | focal adhesion assembly (GO:0048041) | 2.64471662 |
101 | cell-substrate adherens junction assembly (GO:0007045) | 2.64471662 |
102 | amyloid precursor protein catabolic process (GO:0042987) | 2.64250535 |
103 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.62492172 |
104 | establishment of protein localization to plasma membrane (GO:0090002) | 2.61703844 |
105 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.61647641 |
106 | keratinocyte development (GO:0003334) | 2.58485767 |
107 | response to endoplasmic reticulum stress (GO:0034976) | 2.58095447 |
108 | cellular modified amino acid catabolic process (GO:0042219) | 2.57832460 |
109 | trivalent inorganic cation transport (GO:0072512) | 2.56964462 |
110 | ferric iron transport (GO:0015682) | 2.56964462 |
111 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.56758345 |
112 | protein autoprocessing (GO:0016540) | 2.56430510 |
113 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.56094584 |
114 | negative regulation of hormone metabolic process (GO:0032351) | 2.54192266 |
115 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.54192266 |
116 | maternal placenta development (GO:0001893) | 2.51733547 |
117 | trophectodermal cell differentiation (GO:0001829) | 2.51146107 |
118 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.50671916 |
119 | surfactant homeostasis (GO:0043129) | 2.49612874 |
120 | regulation of keratinocyte differentiation (GO:0045616) | 2.48767991 |
121 | vesicle coating (GO:0006901) | 2.48361527 |
122 | activation of protein kinase A activity (GO:0034199) | 2.48076313 |
123 | modified amino acid transport (GO:0072337) | 2.47351450 |
124 | cell adhesion mediated by integrin (GO:0033627) | 2.47348198 |
125 | positive regulation of protein deacetylation (GO:0090312) | 2.46753398 |
126 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.46450414 |
127 | negative regulation of TOR signaling (GO:0032007) | 2.45509927 |
128 | zinc ion transmembrane transport (GO:0071577) | 2.43530877 |
129 | adherens junction assembly (GO:0034333) | 2.43402932 |
130 | sphingomyelin metabolic process (GO:0006684) | 2.43044524 |
131 | potassium ion import (GO:0010107) | 2.42627416 |
132 | growth hormone secretion (GO:0030252) | 2.42358320 |
133 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.41727187 |
134 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.40817955 |
135 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.40689435 |
136 | vesicle targeting (GO:0006903) | 2.40453048 |
137 | norepinephrine metabolic process (GO:0042415) | 2.39715217 |
138 | NADH metabolic process (GO:0006734) | 2.39292342 |
139 | mannose metabolic process (GO:0006013) | 2.38612133 |
140 | positive regulation of actin filament depolymerization (GO:0030836) | 2.38548270 |
141 | regulation of cardioblast differentiation (GO:0051890) | 2.38114264 |
142 | polarized epithelial cell differentiation (GO:0030859) | 2.37769333 |
143 | membrane protein ectodomain proteolysis (GO:0006509) | 2.37608216 |
144 | epithelial cell-cell adhesion (GO:0090136) | 2.37598726 |
145 | cellular sodium ion homeostasis (GO:0006883) | 2.35873009 |
146 | cellular response to nutrient (GO:0031670) | 2.35678524 |
147 | bone resorption (GO:0045453) | 2.35575296 |
148 | mammary gland alveolus development (GO:0060749) | 2.34227947 |
149 | signal complex assembly (GO:0007172) | 2.33729502 |
150 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.33501966 |
151 | negative regulation of fatty acid transport (GO:2000192) | 2.33303466 |
152 | cell-cell junction assembly (GO:0007043) | 2.33198357 |
153 | anterior/posterior axis specification, embryo (GO:0008595) | 2.33128928 |
154 | endocytic recycling (GO:0032456) | 2.32385590 |
155 | pentose-phosphate shunt (GO:0006098) | 2.32201357 |
156 | Golgi organization (GO:0007030) | 2.32122783 |
157 | membrane repolarization (GO:0086009) | 2.32058719 |
158 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.31715186 |
159 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.31532067 |
160 | NLS-bearing protein import into nucleus (GO:0006607) | 2.31205837 |
161 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.31155439 |
162 | positive regulation of vesicle fusion (GO:0031340) | 2.30009786 |
163 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.28929553 |
164 | protein targeting to Golgi (GO:0000042) | 2.28569159 |
165 | regulation of ARF GTPase activity (GO:0032312) | 2.28509866 |
166 | actin filament bundle assembly (GO:0051017) | 2.27923592 |
167 | actin filament bundle organization (GO:0061572) | 2.27923592 |
168 | regulation of tight junction assembly (GO:2000810) | 2.27706352 |
169 | plasma membrane repair (GO:0001778) | 2.27142635 |
170 | response to unfolded protein (GO:0006986) | 2.25765977 |
171 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.25454781 |
172 | maintenance of protein localization in organelle (GO:0072595) | 2.24755777 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.80432110 |
2 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.95433450 |
3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.81288857 |
4 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.74931944 |
5 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.26307724 |
6 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.22976717 |
7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.22415225 |
8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.19450613 |
9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.16828968 |
10 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.16203914 |
11 | MYC_22102868_ChIP-Seq_BL_Human | 2.14790229 |
12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.14410658 |
13 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.04396037 |
14 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.98478159 |
15 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.98478159 |
16 | KDM2B_26808549_Chip-Seq_K562_Human | 1.96821272 |
17 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.93746387 |
18 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.92140778 |
19 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.91221775 |
20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.87939094 |
21 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.86850697 |
22 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.81978271 |
23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80361040 |
24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.80241331 |
25 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.77525646 |
26 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.77379025 |
27 | ATF3_27146783_Chip-Seq_COLON_Human | 1.76934061 |
28 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.74657215 |
29 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.72593128 |
30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71930137 |
31 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.70954851 |
32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67996694 |
33 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.67575498 |
34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.66635512 |
35 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.64723459 |
36 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.64331735 |
37 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.64032730 |
38 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.63266748 |
39 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.60491717 |
40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.59202876 |
41 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.58344520 |
42 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.56811674 |
43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.56591607 |
44 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.56342032 |
45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.55640005 |
46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53963336 |
47 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.53478016 |
48 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.50812181 |
49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.50538791 |
50 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50220693 |
51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49932204 |
52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49668260 |
53 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49080966 |
54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.48684003 |
55 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.47535419 |
56 | P68_20966046_ChIP-Seq_HELA_Human | 1.46969767 |
57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.46804675 |
58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46048261 |
59 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.46044929 |
60 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.45320610 |
61 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.44864224 |
62 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.44843961 |
63 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.43938987 |
64 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.43844198 |
65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42805922 |
66 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.41271390 |
67 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39857716 |
68 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.39618623 |
69 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.38996361 |
70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.38939078 |
71 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.38364147 |
72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.37571015 |
73 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.36628438 |
74 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.36535965 |
75 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.36004500 |
76 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.35566051 |
77 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.35159028 |
78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34997293 |
79 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.33571210 |
80 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.32840371 |
81 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.32553068 |
82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31346277 |
83 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.30387340 |
84 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.30375834 |
85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30075663 |
86 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.29654551 |
87 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28289516 |
88 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.28222075 |
89 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.27944913 |
90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27760575 |
91 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26634576 |
92 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.26629958 |
93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.25730383 |
94 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.24454496 |
95 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24207647 |
96 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.23678785 |
97 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.21916334 |
98 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21175737 |
99 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.16877523 |
100 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.16877523 |
101 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.16877523 |
102 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16359540 |
103 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.16197893 |
104 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16165157 |
105 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.16025649 |
106 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15202383 |
107 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14414767 |
108 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12754971 |
109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12568138 |
110 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11921038 |
111 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.11311271 |
112 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11299721 |
113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11260117 |
114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10936772 |
115 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.10542643 |
116 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10423011 |
117 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10422862 |
118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10152667 |
119 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10073821 |
120 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.10039594 |
121 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09877169 |
122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09313151 |
123 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09067286 |
124 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08946362 |
125 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.08701987 |
126 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.08537641 |
127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07823875 |
128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07530156 |
129 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.07133289 |
130 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.06826051 |
131 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06668386 |
132 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05837313 |
133 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.05119193 |
134 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04438333 |
135 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04081190 |
136 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01496305 |
137 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98215093 |
138 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98110417 |
139 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.97635454 |
140 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.95432394 |
141 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.94849031 |
142 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93162558 |
143 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91962765 |
144 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.90899515 |
145 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90560823 |
146 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.88485629 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004043_abnormal_pH_regulation | 3.97672732 |
2 | MP0008961_abnormal_basal_metabolism | 3.58018662 |
3 | MP0010234_abnormal_vibrissa_follicle | 3.54748800 |
4 | MP0000579_abnormal_nail_morphology | 3.39767713 |
5 | MP0004264_abnormal_extraembryonic_tissu | 3.28843308 |
6 | MP0010678_abnormal_skin_adnexa | 3.11169601 |
7 | MP0003705_abnormal_hypodermis_morpholog | 3.00974498 |
8 | MP0003283_abnormal_digestive_organ | 2.93986943 |
9 | MP0004859_abnormal_synaptic_plasticity | 2.82547613 |
10 | MP0002909_abnormal_adrenal_gland | 2.73478081 |
11 | MP0004858_abnormal_nervous_system | 2.64278103 |
12 | MP0005058_abnormal_lysosome_morphology | 2.63076493 |
13 | MP0002877_abnormal_melanocyte_morpholog | 2.57597863 |
14 | MP0005409_darkened_coat_color | 2.43854821 |
15 | MP0003172_abnormal_lysosome_physiology | 2.38817797 |
16 | MP0005451_abnormal_body_composition | 2.30846533 |
17 | MP0002098_abnormal_vibrissa_morphology | 2.28895781 |
18 | MP0005501_abnormal_skin_physiology | 2.26560210 |
19 | MP0003941_abnormal_skin_development | 2.20426875 |
20 | MP0009840_abnormal_foam_cell | 2.15158695 |
21 | MP0002060_abnormal_skin_morphology | 2.13274817 |
22 | MP0003300_gastrointestinal_ulcer | 2.11566183 |
23 | MP0010352_gastrointestinal_tract_polyps | 2.10508870 |
24 | MP0004381_abnormal_hair_follicle | 2.08382636 |
25 | MP0001216_abnormal_epidermal_layer | 2.07935816 |
26 | MP0009780_abnormal_chondrocyte_physiolo | 2.07360121 |
27 | MP0003566_abnormal_cell_adhesion | 2.00297078 |
28 | MP0001765_abnormal_ion_homeostasis | 1.95678562 |
29 | MP0000013_abnormal_adipose_tissue | 1.95480327 |
30 | MP0001756_abnormal_urination | 1.92514157 |
31 | MP0009643_abnormal_urine_homeostasis | 1.86880140 |
32 | MP0000377_abnormal_hair_follicle | 1.82924460 |
33 | MP0000383_abnormal_hair_follicle | 1.80487812 |
34 | MP0004185_abnormal_adipocyte_glucose | 1.78723223 |
35 | MP0002653_abnormal_ependyma_morphology | 1.78390855 |
36 | MP0000627_abnormal_mammary_gland | 1.72982011 |
37 | MP0008260_abnormal_autophagy | 1.72546474 |
38 | MP0005076_abnormal_cell_differentiation | 1.69272869 |
39 | MP0005408_hypopigmentation | 1.66407073 |
40 | MP0003329_amyloid_beta_deposits | 1.64290223 |
41 | MP0001849_ear_inflammation | 1.62256815 |
42 | MP0005248_abnormal_Harderian_gland | 1.60751229 |
43 | MP0000467_abnormal_esophagus_morphology | 1.58861949 |
44 | MP0000003_abnormal_adipose_tissue | 1.57674123 |
45 | MP0010771_integument_phenotype | 1.54687895 |
46 | MP0003045_fibrosis | 1.53959628 |
47 | MP0004782_abnormal_surfactant_physiolog | 1.52573121 |
48 | MP0000427_abnormal_hair_cycle | 1.47582311 |
49 | MP0000678_abnormal_parathyroid_gland | 1.45181981 |
50 | MP0004885_abnormal_endolymph | 1.44697627 |
51 | MP0001881_abnormal_mammary_gland | 1.41202368 |
52 | MP0002254_reproductive_system_inflammat | 1.41063237 |
53 | MP0003075_altered_response_to | 1.38812985 |
54 | MP0005310_abnormal_salivary_gland | 1.38156898 |
55 | MP0000462_abnormal_digestive_system | 1.36952807 |
56 | MP0004019_abnormal_vitamin_homeostasis | 1.34923408 |
57 | MP0005332_abnormal_amino_acid | 1.34445675 |
58 | MP0002269_muscular_atrophy | 1.30455093 |
59 | MP0000762_abnormal_tongue_morphology | 1.29221641 |
60 | MP0001346_abnormal_lacrimal_gland | 1.28862327 |
61 | MP0003183_abnormal_peptide_metabolism | 1.26910234 |
62 | MP0005375_adipose_tissue_phenotype | 1.26496672 |
63 | MP0004233_abnormal_muscle_weight | 1.25734672 |
64 | MP0000537_abnormal_urethra_morphology | 1.21416022 |
65 | MP0005666_abnormal_adipose_tissue | 1.19693120 |
66 | MP0001727_abnormal_embryo_implantation | 1.18386761 |
67 | MP0003195_calcinosis | 1.14496625 |
68 | MP0002136_abnormal_kidney_physiology | 1.13444079 |
69 | MP0003656_abnormal_erythrocyte_physiolo | 1.13161925 |
70 | MP0001944_abnormal_pancreas_morphology | 1.12213125 |
71 | MP0003191_abnormal_cellular_cholesterol | 1.11170015 |
72 | MP0001666_abnormal_nutrient_absorption | 1.08714722 |
73 | MP0004084_abnormal_cardiac_muscle | 1.08218252 |
74 | MP0005167_abnormal_blood-brain_barrier | 1.07747727 |
75 | MP0004130_abnormal_muscle_cell | 1.05088398 |
76 | MP0002078_abnormal_glucose_homeostasis | 1.02744794 |
77 | MP0000367_abnormal_coat/_hair | 1.00801337 |
78 | MP0000747_muscle_weakness | 1.00591127 |
79 | MP0010307_abnormal_tumor_latency | 1.00338619 |
80 | MP0000604_amyloidosis | 0.98902227 |
81 | MP0009931_abnormal_skin_appearance | 0.98652705 |
82 | MP0002234_abnormal_pharynx_morphology | 0.98120352 |
83 | MP0001348_abnormal_lacrimal_gland | 0.97681329 |
84 | MP0005636_abnormal_mineral_homeostasis | 0.97510994 |
85 | MP0004270_analgesia | 0.97013247 |
86 | MP0004947_skin_inflammation | 0.95778689 |
87 | MP0002086_abnormal_extraembryonic_tissu | 0.94509661 |
88 | MP0001958_emphysema | 0.93157663 |
89 | MP0003123_paternal_imprinting | 0.92761374 |
90 | MP0002896_abnormal_bone_mineralization | 0.90747981 |
91 | MP0005670_abnormal_white_adipose | 0.90268940 |
92 | MP0005257_abnormal_intraocular_pressure | 0.88273780 |
93 | MP0005075_abnormal_melanosome_morpholog | 0.86542417 |
94 | MP0001730_embryonic_growth_arrest | 0.86361837 |
95 | MP0002693_abnormal_pancreas_physiology | 0.86282502 |
96 | MP0003011_delayed_dark_adaptation | 0.85626186 |
97 | MP0003890_abnormal_embryonic-extraembry | 0.84141602 |
98 | MP0005360_urolithiasis | 0.83456050 |
99 | MP0006035_abnormal_mitochondrial_morpho | 0.83318493 |
100 | MP0000566_synostosis | 0.83109954 |
101 | MP0003119_abnormal_digestive_system | 0.82613070 |
102 | MP0000015_abnormal_ear_pigmentation | 0.80157584 |
103 | MP0005319_abnormal_enzyme/_coenzyme | 0.79963224 |
104 | MP0005379_endocrine/exocrine_gland_phen | 0.79413872 |
105 | MP0003091_abnormal_cell_migration | 0.79231090 |
106 | MP0003984_embryonic_growth_retardation | 0.78968939 |
107 | MP0002088_abnormal_embryonic_growth/wei | 0.78094643 |
108 | MP0005023_abnormal_wound_healing | 0.76992772 |
109 | MP0003303_peritoneal_inflammation | 0.76890850 |
110 | MP0005623_abnormal_meninges_morphology | 0.76828391 |
111 | MP0000609_abnormal_liver_physiology | 0.76512100 |
112 | MP0001672_abnormal_embryogenesis/_devel | 0.76109323 |
113 | MP0005380_embryogenesis_phenotype | 0.76109323 |
114 | MP0005621_abnormal_cell_physiology | 0.74421947 |
115 | MP0009672_abnormal_birth_weight | 0.71459461 |
116 | MP0002090_abnormal_vision | 0.70678637 |
117 | MP0002118_abnormal_lipid_homeostasis | 0.70648551 |
118 | MP0003635_abnormal_synaptic_transmissio | 0.70455487 |
119 | MP0000358_abnormal_cell_content/ | 0.70351143 |
120 | MP0003879_abnormal_hair_cell | 0.70112598 |
121 | MP0005083_abnormal_biliary_tract | 0.69834975 |
122 | MP0002796_impaired_skin_barrier | 0.68813607 |
123 | MP0002138_abnormal_hepatobiliary_system | 0.68801786 |
124 | MP0005377_hearing/vestibular/ear_phenot | 0.68492901 |
125 | MP0003878_abnormal_ear_physiology | 0.68492901 |
126 | MP0001191_abnormal_skin_condition | 0.67963796 |
127 | MP0002089_abnormal_postnatal_growth/wei | 0.67826941 |
128 | MP0003953_abnormal_hormone_level | 0.66196687 |
129 | MP0004272_abnormal_basement_membrane | 0.66098724 |
130 | MP0002168_other_aberrant_phenotype | 0.65985758 |
131 | MP0003453_abnormal_keratinocyte_physiol | 0.65610654 |
132 | MP0000647_abnormal_sebaceous_gland | 0.65120081 |
133 | MP0001873_stomach_inflammation | 0.65100903 |
134 | MP0002084_abnormal_developmental_patter | 0.64486281 |
135 | MP0002080_prenatal_lethality | 0.63027243 |
136 | MP0000858_altered_metastatic_potential | 0.62830000 |
137 | MP0003252_abnormal_bile_duct | 0.62181627 |
138 | MP0005220_abnormal_exocrine_pancreas | 0.62143645 |
139 | MP0010329_abnormal_lipoprotein_level | 0.61900358 |
140 | MP0002970_abnormal_white_adipose | 0.60344355 |
141 | MP0004087_abnormal_muscle_fiber | 0.60215185 |
142 | MP0002837_dystrophic_cardiac_calcinosis | 0.59820513 |
143 | MP0001697_abnormal_embryo_size | 0.59609891 |
144 | MP0005384_cellular_phenotype | 0.58149967 |
145 | MP0005365_abnormal_bile_salt | 0.58130691 |
146 | MP0000350_abnormal_cell_proliferation | 0.55593430 |
147 | MP0008874_decreased_physiological_sensi | 0.54488380 |
148 | MP0005165_increased_susceptibility_to | 0.54141571 |
149 | MP0003634_abnormal_glial_cell | 0.53859081 |
150 | MP0003943_abnormal_hepatobiliary_system | 0.50308190 |
151 | MP0008875_abnormal_xenobiotic_pharmacok | 0.49776315 |
152 | MP0003936_abnormal_reproductive_system | 0.49053474 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Right ventricular cardiomyopathy (HP:0011663) | 4.75349797 |
2 | Gout (HP:0001997) | 4.61754976 |
3 | Hyperactive renin-angiotensin system (HP:0000841) | 3.72381576 |
4 | Onycholysis (HP:0001806) | 3.70789518 |
5 | Milia (HP:0001056) | 3.62229190 |
6 | Plantar hyperkeratosis (HP:0007556) | 3.47309979 |
7 | Hand muscle atrophy (HP:0009130) | 3.40913325 |
8 | Fragile nails (HP:0001808) | 3.37257918 |
9 | Abnormality of nail color (HP:0100643) | 3.34362471 |
10 | Abnormality of the lower motor neuron (HP:0002366) | 3.33620292 |
11 | Septate vagina (HP:0001153) | 3.29019144 |
12 | Abnormal hair laboratory examination (HP:0003328) | 3.25017222 |
13 | Distal upper limb amyotrophy (HP:0007149) | 3.24528730 |
14 | Upper limb amyotrophy (HP:0009129) | 3.24528730 |
15 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.15818834 |
16 | Hypokinesia (HP:0002375) | 3.13748907 |
17 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.13486541 |
18 | Mucopolysacchariduria (HP:0008155) | 3.13486541 |
19 | Abnormality of chloride homeostasis (HP:0011422) | 3.00017504 |
20 | Increased circulating renin level (HP:0000848) | 2.99786707 |
21 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.91960831 |
22 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.91960831 |
23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.91960831 |
24 | Global brain atrophy (HP:0002283) | 2.90117244 |
25 | Dysostosis multiplex (HP:0000943) | 2.87888540 |
26 | Resting tremor (HP:0002322) | 2.86435817 |
27 | Hypokalemic alkalosis (HP:0001949) | 2.80677569 |
28 | Nail dystrophy (HP:0008404) | 2.76648545 |
29 | Increased cerebral lipofuscin (HP:0011813) | 2.75001287 |
30 | Micronodular cirrhosis (HP:0001413) | 2.74179021 |
31 | Cerebral aneurysm (HP:0004944) | 2.72660254 |
32 | Ketoacidosis (HP:0001993) | 2.71653350 |
33 | Supranuclear gaze palsy (HP:0000605) | 2.69672743 |
34 | Growth hormone excess (HP:0000845) | 2.69514774 |
35 | Lip pit (HP:0100267) | 2.62555459 |
36 | Renal salt wasting (HP:0000127) | 2.60893490 |
37 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.56833014 |
38 | Atrophic scars (HP:0001075) | 2.56534402 |
39 | Palmoplantar hyperkeratosis (HP:0000972) | 2.55453582 |
40 | Alopecia of scalp (HP:0002293) | 2.54404420 |
41 | Thick nail (HP:0001805) | 2.52472646 |
42 | Insidious onset (HP:0003587) | 2.50374932 |
43 | Termporal pattern (HP:0011008) | 2.50374932 |
44 | Increased purine levels (HP:0004368) | 2.45054516 |
45 | Hyperuricemia (HP:0002149) | 2.45054516 |
46 | Hyperparathyroidism (HP:0000843) | 2.42412859 |
47 | Selective tooth agenesis (HP:0001592) | 2.38209676 |
48 | Sparse eyelashes (HP:0000653) | 2.36351372 |
49 | Metabolic alkalosis (HP:0200114) | 2.33793623 |
50 | Bundle branch block (HP:0011710) | 2.33328060 |
51 | Abnormality of renin-angiotensin system (HP:0000847) | 2.29815400 |
52 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.29594398 |
53 | Palmar hyperkeratosis (HP:0010765) | 2.27957130 |
54 | Advanced eruption of teeth (HP:0006288) | 2.27611214 |
55 | Loss of speech (HP:0002371) | 2.26646253 |
56 | Apathy (HP:0000741) | 2.24719274 |
57 | Hypoplasia of dental enamel (HP:0006297) | 2.23881402 |
58 | Hyperaldosteronism (HP:0000859) | 2.23494857 |
59 | Unilateral renal agenesis (HP:0000122) | 2.23395695 |
60 | Abnormality of purine metabolism (HP:0004352) | 2.22344027 |
61 | Curly hair (HP:0002212) | 2.21584232 |
62 | Ankle clonus (HP:0011448) | 2.21202804 |
63 | Mitral stenosis (HP:0001718) | 2.20978291 |
64 | Hyperglycinuria (HP:0003108) | 2.20187815 |
65 | Distal lower limb muscle weakness (HP:0009053) | 2.19969936 |
66 | Symptomatic seizures (HP:0011145) | 2.19539556 |
67 | Neurofibrillary tangles (HP:0002185) | 2.19417771 |
68 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17535348 |
69 | Ventricular fibrillation (HP:0001663) | 2.16074657 |
70 | Asymmetry of the thorax (HP:0001555) | 2.15421341 |
71 | Achilles tendon contracture (HP:0001771) | 2.13693665 |
72 | J-shaped sella turcica (HP:0002680) | 2.12722524 |
73 | Ependymoma (HP:0002888) | 2.12378181 |
74 | Adrenal overactivity (HP:0002717) | 2.12134241 |
75 | Cervical subluxation (HP:0003308) | 2.11281356 |
76 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.10014283 |
77 | Multiple enchondromatosis (HP:0005701) | 2.09819276 |
78 | Abnormality of the gastric mucosa (HP:0004295) | 2.09539646 |
79 | Ridged nail (HP:0001807) | 2.09001134 |
80 | Vascular calcification (HP:0004934) | 2.08006036 |
81 | Sparse lateral eyebrow (HP:0005338) | 2.07320894 |
82 | Hypoglycemic coma (HP:0001325) | 2.07300508 |
83 | Visual hallucinations (HP:0002367) | 2.07204045 |
84 | Diminished motivation (HP:0000745) | 2.06730765 |
85 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.06201275 |
86 | Abnormality of the Achilles tendon (HP:0005109) | 2.05767035 |
87 | Abnormal blistering of the skin (HP:0008066) | 2.03928802 |
88 | Autoamputation (HP:0001218) | 2.03712871 |
89 | Tetany (HP:0001281) | 2.03213300 |
90 | Aplasia cutis congenita (HP:0001057) | 2.02794580 |
91 | Abnormality of the salivary glands (HP:0010286) | 2.02324828 |
92 | Spinal muscular atrophy (HP:0007269) | 2.01780138 |
93 | Vertebral compression fractures (HP:0002953) | 2.01159539 |
94 | Hypercortisolism (HP:0001578) | 2.00773625 |
95 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00637173 |
96 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00637173 |
97 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00637173 |
98 | Hypotrichosis (HP:0001006) | 1.99948235 |
99 | Progressive hearing impairment (HP:0001730) | 1.99505607 |
100 | Difficulty climbing stairs (HP:0003551) | 1.98048640 |
101 | Tongue fasciculations (HP:0001308) | 1.97470256 |
102 | Hypokalemia (HP:0002900) | 1.97046415 |
103 | Aneurysm (HP:0002617) | 1.96854244 |
104 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.96444652 |
105 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95248313 |
106 | Increased CSF protein (HP:0002922) | 1.94447449 |
107 | Stridor (HP:0010307) | 1.93933738 |
108 | Diminished movement (HP:0002374) | 1.92621712 |
109 | Ankyloglossia (HP:0010296) | 1.92086027 |
110 | Overlapping toe (HP:0001845) | 1.91772600 |
111 | Turricephaly (HP:0000262) | 1.91508958 |
112 | Interstitial pulmonary disease (HP:0006530) | 1.91333479 |
113 | Testicular neoplasm (HP:0010788) | 1.90896666 |
114 | Trismus (HP:0000211) | 1.90751353 |
115 | Hypoglycemic seizures (HP:0002173) | 1.90700960 |
116 | Polycythemia (HP:0001901) | 1.90464505 |
117 | Polyuria (HP:0000103) | 1.90191027 |
118 | Abnormal gallbladder physiology (HP:0012438) | 1.89139975 |
119 | Cholecystitis (HP:0001082) | 1.89139975 |
120 | Insomnia (HP:0100785) | 1.88785653 |
121 | Hyperglycemia (HP:0003074) | 1.88569672 |
122 | Abnormal urine output (HP:0012590) | 1.88512607 |
123 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.87543356 |
124 | Abdominal distention (HP:0003270) | 1.86048835 |
125 | Metaphyseal cupping (HP:0003021) | 1.85634536 |
126 | Broad face (HP:0000283) | 1.85430500 |
127 | Pterygium (HP:0001059) | 1.84727370 |
128 | Neonatal death (HP:0003811) | 1.83753788 |
129 | Neuronal loss in central nervous system (HP:0002529) | 1.82263560 |
130 | Progressive neurologic deterioration (HP:0002344) | 1.82173167 |
131 | Distal lower limb amyotrophy (HP:0008944) | 1.82160085 |
132 | Abnormality of the astrocytes (HP:0100707) | 1.81094205 |
133 | Astrocytoma (HP:0009592) | 1.81094205 |
134 | Abnormality of renal excretion (HP:0011036) | 1.80438476 |
135 | Hypotension (HP:0002615) | 1.80191249 |
136 | Abnormality of sodium homeostasis (HP:0010931) | 1.80072135 |
137 | Neoplasm of the heart (HP:0100544) | 1.79980650 |
138 | Rapidly progressive (HP:0003678) | 1.79491919 |
139 | Akinesia (HP:0002304) | 1.79126615 |
140 | Progressive muscle weakness (HP:0003323) | 1.78332102 |
141 | Testicular atrophy (HP:0000029) | 1.78066297 |
142 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.78043770 |
143 | Ulnar bowing (HP:0003031) | 1.77874334 |
144 | Asymmetric septal hypertrophy (HP:0001670) | 1.76675878 |
145 | Spinal cord compression (HP:0002176) | 1.75836234 |
146 | Freckling (HP:0001480) | 1.75573874 |
147 | Cerebral inclusion bodies (HP:0100314) | 1.74690558 |
148 | Long palpebral fissure (HP:0000637) | 1.74408917 |
149 | Flat acetabular roof (HP:0003180) | 1.74400897 |
150 | Hyperphosphatemia (HP:0002905) | 1.74367449 |
151 | Macroorchidism (HP:0000053) | 1.73784640 |
152 | Abnormality of potassium homeostasis (HP:0011042) | 1.72599622 |
153 | Muscle fibrillation (HP:0010546) | 1.71925700 |
154 | Late onset (HP:0003584) | 1.70608350 |
155 | Hyperacusis (HP:0010780) | 1.70321766 |
156 | Tetraplegia (HP:0002445) | 1.69839608 |
157 | Hyperthyroidism (HP:0000836) | 1.69526541 |
158 | Hamartoma of the eye (HP:0010568) | 1.69453489 |
159 | Posterior subcapsular cataract (HP:0007787) | 1.69225539 |
160 | Subacute progressive viral hepatitis (HP:0006572) | 1.68851240 |
161 | Long toe (HP:0010511) | 1.68784905 |
162 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.67723316 |
163 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.67723316 |
164 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.67718354 |
165 | Dysmetric saccades (HP:0000641) | 1.66553011 |
166 | Increased connective tissue (HP:0009025) | 1.66488036 |
167 | Retinal atrophy (HP:0001105) | 1.66344132 |
168 | Ketosis (HP:0001946) | 1.65566247 |
169 | Malnutrition (HP:0004395) | 1.65490931 |
170 | Spastic tetraparesis (HP:0001285) | 1.65410955 |
171 | Hyponatremia (HP:0002902) | 1.65292412 |
172 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.65055283 |
173 | Status epilepticus (HP:0002133) | 1.63949806 |
174 | Abnormal cartilage morphology (HP:0002763) | 1.61568542 |
175 | EMG: neuropathic changes (HP:0003445) | 1.61479905 |
176 | Severe short stature (HP:0003510) | 1.61153412 |
177 | Hypomagnesemia (HP:0002917) | 1.59742854 |
178 | Pili torti (HP:0003777) | 1.59279817 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST1R | 4.21896839 |
2 | TRIB3 | 3.94595172 |
3 | ERN1 | 3.21191024 |
4 | MAP3K9 | 2.98348135 |
5 | PRKD3 | 2.97344744 |
6 | TESK1 | 2.81375377 |
7 | CDK12 | 2.54185817 |
8 | KSR2 | 2.39445221 |
9 | MAP3K12 | 2.37954086 |
10 | TRIM28 | 2.20280730 |
11 | TAOK1 | 2.08431806 |
12 | NEK1 | 2.01858647 |
13 | SIK3 | 1.98287868 |
14 | EPHA2 | 1.96090802 |
15 | NTRK1 | 1.89656554 |
16 | RIPK1 | 1.85229637 |
17 | WNK4 | 1.79887512 |
18 | PDGFRA | 1.78578522 |
19 | MAP3K2 | 1.77277732 |
20 | SCYL2 | 1.76948523 |
21 | EIF2AK1 | 1.72471794 |
22 | ALK | 1.71731413 |
23 | PKN2 | 1.71618132 |
24 | TYRO3 | 1.64945782 |
25 | SMG1 | 1.61839003 |
26 | MST4 | 1.57110562 |
27 | STK38 | 1.55767364 |
28 | WNK3 | 1.53753507 |
29 | DAPK2 | 1.53328831 |
30 | IRAK3 | 1.49331310 |
31 | PAK6 | 1.44736735 |
32 | EEF2K | 1.39458307 |
33 | GRK6 | 1.39196940 |
34 | PTK2 | 1.38583204 |
35 | CAMKK1 | 1.33223642 |
36 | GRK5 | 1.30750876 |
37 | LIMK1 | 1.26640898 |
38 | NEK6 | 1.26295225 |
39 | STK10 | 1.20929470 |
40 | LRRK2 | 1.20723025 |
41 | DDR2 | 1.18221540 |
42 | NME2 | 1.17770005 |
43 | PTK6 | 1.17662463 |
44 | LATS2 | 1.15915995 |
45 | PAK4 | 1.14198617 |
46 | PRKCH | 1.09180009 |
47 | WNK1 | 1.05602970 |
48 | BMX | 1.05310872 |
49 | RPS6KB2 | 1.04298357 |
50 | NTRK3 | 1.02220479 |
51 | PBK | 1.02110373 |
52 | ICK | 1.01278437 |
53 | SIK1 | 1.00090059 |
54 | PAK3 | 0.99487010 |
55 | YES1 | 0.98552232 |
56 | EPHA4 | 0.97992054 |
57 | MAP3K1 | 0.97388105 |
58 | PHKG2 | 0.93721900 |
59 | PHKG1 | 0.93721900 |
60 | LMTK2 | 0.93429219 |
61 | HIPK2 | 0.92401180 |
62 | PRKD2 | 0.91712258 |
63 | MTOR | 0.90080294 |
64 | FGFR3 | 0.89334099 |
65 | AKT3 | 0.88661296 |
66 | NME1 | 0.88311199 |
67 | DAPK1 | 0.87421389 |
68 | SGK3 | 0.84835873 |
69 | RET | 0.84575121 |
70 | MAP3K10 | 0.83942844 |
71 | STK24 | 0.83588158 |
72 | LATS1 | 0.83002182 |
73 | FER | 0.82268306 |
74 | MAP2K1 | 0.81066988 |
75 | PRPF4B | 0.80857011 |
76 | MAP3K7 | 0.80606397 |
77 | MAPKAPK3 | 0.79755433 |
78 | PDPK1 | 0.78158390 |
79 | PDK1 | 0.77521357 |
80 | TSSK6 | 0.74519056 |
81 | INSRR | 0.72388828 |
82 | OXSR1 | 0.70932437 |
83 | ILK | 0.70090433 |
84 | MATK | 0.68684680 |
85 | FGFR2 | 0.68506652 |
86 | PDK4 | 0.68351637 |
87 | PDK3 | 0.68351637 |
88 | CDC42BPA | 0.68011101 |
89 | MARK2 | 0.66695604 |
90 | ERBB4 | 0.64822914 |
91 | TTN | 0.62941328 |
92 | JAK2 | 0.62149995 |
93 | PRKAA1 | 0.60937060 |
94 | PINK1 | 0.59705639 |
95 | TAOK3 | 0.59642223 |
96 | PRKCI | 0.59425156 |
97 | CAMK2G | 0.59046470 |
98 | PRKG2 | 0.58902564 |
99 | DMPK | 0.57976332 |
100 | BRSK1 | 0.56427297 |
101 | PDGFRB | 0.56143902 |
102 | TGFBR2 | 0.55866073 |
103 | CDK7 | 0.55569730 |
104 | DYRK1B | 0.55287010 |
105 | MAP3K8 | 0.55016547 |
106 | BCKDK | 0.54135037 |
107 | ARAF | 0.53560476 |
108 | PDK2 | 0.52130189 |
109 | MAP3K3 | 0.51852984 |
110 | TESK2 | 0.50625883 |
111 | MAP3K13 | 0.50394331 |
112 | MAP3K11 | 0.50060970 |
113 | CAMK2B | 0.48924338 |
114 | ROCK2 | 0.47955259 |
115 | GSK3A | 0.47751944 |
116 | EPHB1 | 0.47595200 |
117 | AKT2 | 0.46951296 |
118 | MET | 0.46547835 |
119 | FGFR4 | 0.46536142 |
120 | CDK5 | 0.46151137 |
121 | PRKD1 | 0.45963494 |
122 | RAF1 | 0.43409026 |
123 | PASK | 0.43168670 |
124 | MAP2K2 | 0.43048826 |
125 | MAPK15 | 0.42638001 |
126 | STK38L | 0.41308326 |
127 | STK11 | 0.40691883 |
128 | CAMK2D | 0.40539057 |
129 | ERBB3 | 0.40478423 |
130 | FLT3 | 0.39696809 |
131 | CAMK4 | 0.39308960 |
132 | DAPK3 | 0.39124487 |
133 | TTK | 0.38997209 |
134 | BMPR2 | 0.38418305 |
135 | KSR1 | 0.38208083 |
136 | JAK1 | 0.37805794 |
137 | PIK3CA | 0.36644242 |
138 | BRD4 | 0.36622758 |
139 | TBK1 | 0.34731532 |
140 | EPHA3 | 0.33064293 |
141 | RPS6KA2 | 0.32983850 |
142 | CDK9 | 0.32281765 |
143 | RPS6KB1 | 0.31903588 |
144 | BRAF | 0.30178683 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.83498538 |
2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.63408271 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.63216727 |
4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.23616108 |
5 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.01019676 |
6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.93483387 |
7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.92458813 |
8 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.88163493 |
9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.87013991 |
10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.71875083 |
11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.71481642 |
12 | Lysosome_Homo sapiens_hsa04142 | 1.71275137 |
13 | Insulin secretion_Homo sapiens_hsa04911 | 1.69071575 |
14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.54578720 |
15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.54051395 |
16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.51155611 |
17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.49116998 |
18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43022461 |
19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.41300849 |
20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.41015691 |
21 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.40928894 |
22 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.39438768 |
23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.37309625 |
24 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.35984357 |
25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.34726488 |
26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.31124292 |
27 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.30846728 |
28 | Bile secretion_Homo sapiens_hsa04976 | 1.30535167 |
29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27782642 |
30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24510352 |
31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.17623756 |
32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17556536 |
33 | Hepatitis C_Homo sapiens_hsa05160 | 1.16991270 |
34 | Glioma_Homo sapiens_hsa05214 | 1.14763233 |
35 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.14400732 |
36 | Bladder cancer_Homo sapiens_hsa05219 | 1.11391331 |
37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07654808 |
38 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.05898107 |
39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05471969 |
40 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.04709250 |
41 | Insulin resistance_Homo sapiens_hsa04931 | 1.03089668 |
42 | Salivary secretion_Homo sapiens_hsa04970 | 1.01539808 |
43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.01409612 |
44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99755991 |
45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.99179293 |
46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95241073 |
47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.94688305 |
48 | Mineral absorption_Homo sapiens_hsa04978 | 0.94148306 |
49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.92150555 |
50 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90580562 |
51 | Endocytosis_Homo sapiens_hsa04144 | 0.90526798 |
52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89775228 |
53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89270100 |
54 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88641486 |
55 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.87032328 |
56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86258528 |
57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.85970357 |
58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85549280 |
59 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84816899 |
60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83209377 |
61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83029112 |
62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82858004 |
63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82491884 |
64 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82295270 |
65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81001867 |
66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80759628 |
67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78898053 |
68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78557694 |
69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76248969 |
70 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76234416 |
71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.75406276 |
72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75331799 |
73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75225115 |
74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74775150 |
75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74515345 |
76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73227234 |
77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72483390 |
78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72309401 |
79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70220029 |
80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70015950 |
81 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.69955090 |
82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68260664 |
83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68192188 |
84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68185849 |
85 | Circadian entrainment_Homo sapiens_hsa04713 | 0.66878189 |
86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66748313 |
87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66227004 |
88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66181648 |
89 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.66096302 |
90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65767414 |
91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.65624668 |
92 | Prostate cancer_Homo sapiens_hsa05215 | 0.64639301 |
93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64339506 |
94 | Proteasome_Homo sapiens_hsa03050 | 0.64299212 |
95 | Phototransduction_Homo sapiens_hsa04744 | 0.63875400 |
96 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63397910 |
97 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.63339282 |
98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63252349 |
99 | Tight junction_Homo sapiens_hsa04530 | 0.61869308 |
100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.61844996 |
101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61679840 |
102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61499470 |
103 | GABAergic synapse_Homo sapiens_hsa04727 | 0.61365003 |
104 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61048448 |
105 | Lysine degradation_Homo sapiens_hsa00310 | 0.59558518 |
106 | Shigellosis_Homo sapiens_hsa05131 | 0.59296551 |
107 | Gap junction_Homo sapiens_hsa04540 | 0.58556100 |
108 | Focal adhesion_Homo sapiens_hsa04510 | 0.58342862 |
109 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57984232 |
110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56658813 |
111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56187891 |
112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55997682 |
113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55500602 |
114 | Adherens junction_Homo sapiens_hsa04520 | 0.54577996 |
115 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53613238 |
116 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.53338869 |
117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52647993 |
118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51325372 |
119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51125347 |
120 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51120139 |
121 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50484550 |
122 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50424524 |
123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50407410 |
124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50394696 |
125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49643302 |
126 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49577297 |
127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44197358 |
128 | Prion diseases_Homo sapiens_hsa05020 | 0.44027117 |
129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39111946 |
130 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37631247 |